Search research articles
Contact Us
Filters
Showing results (21-30 of 28) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 28 results.
Renal Failure
|
October 28, 2025
Leukocyte telomere length mediates the association between SIRI and CKD: insights from NHANES 1999-2002
Xiangyun Dang, Guiqing Xu, Huixian Li, et al.
American Journal of Nephrology
|
May 19, 2025
Additive Obinutuzumab Achieves High Remission Rates in Rituximab-Refractory Membranous Nephropathy
Huixian Li, Li Jin, Xinfang Xie, et al.
European Journal of Medicinal Chemistry
|
August 14, 2021
Structure-activity relationship investigation for imidazopyrazole-3-carboxamide derivatives as novel selective inhibitors of Bruton's tyrosine kinase
Dandan Zhang, Guiqing Xu, Jie Zhao, et al.
Drug Design, Development and Therapy
|
October 28, 2025
Design, Synthesis and Antiproliferative Activity Studies of Novel 1,2,3-Triazole-Urea Hybrids
En Gao, Haoying Zhang, Yajie Guo, et al.
Scientific Reports
|
April 22, 2024
Discovery of gefitinib-1,2,3-triazole derivatives against lung cancer via inducing apoptosis and inhibiting the colony formation
En Gao, Ya Wang, Gao-Lu Fan, et al.
The Prostate
|
June 19, 2019
Targeting POH1 inhibits prostate cancer cell growth and enhances the suppressive efficacy of androgen deprivation and docetaxel
Wandong Yu, Junhong Li, Qiang Wang, et al.
Journal of Medicinal Chemistry
|
October 21, 2021
Discovery of 1-Amino-1<i>H</i>-imidazole-5-carboxamide Derivatives as Highly Selective, Covalent Bruton's Tyrosine Kinase (BTK) Inhibitors
Chunhua Ma, Qingyun Li, Minghao Zhao, et al.
Journal of Medicinal Chemistry
|
May 15, 2025
Discovery of Imidazo[1,2-<i>b</i>]pyridazine Derivatives as Potent and Highly Selective Irreversible Bruton's Tyrosine Kinase (BTK) Inhibitors
Dandan Zhang, Jie Zhao, Guiqing Xu, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 28) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 28 results.
Renal Failure
|
October 28, 2025
Leukocyte telomere length mediates the association between SIRI and CKD: insights from NHANES 1999-2002
Xiangyun Dang, Guiqing Xu, Huixian Li, et al.
American Journal of Nephrology
|
May 19, 2025
Additive Obinutuzumab Achieves High Remission Rates in Rituximab-Refractory Membranous Nephropathy
Huixian Li, Li Jin, Xinfang Xie, et al.
European Journal of Medicinal Chemistry
|
August 14, 2021
Structure-activity relationship investigation for imidazopyrazole-3-carboxamide derivatives as novel selective inhibitors of Bruton's tyrosine kinase
Dandan Zhang, Guiqing Xu, Jie Zhao, et al.
Drug Design, Development and Therapy
|
October 28, 2025
Design, Synthesis and Antiproliferative Activity Studies of Novel 1,2,3-Triazole-Urea Hybrids
En Gao, Haoying Zhang, Yajie Guo, et al.
Scientific Reports
|
April 22, 2024
Discovery of gefitinib-1,2,3-triazole derivatives against lung cancer via inducing apoptosis and inhibiting the colony formation
En Gao, Ya Wang, Gao-Lu Fan, et al.
The Prostate
|
June 19, 2019
Targeting POH1 inhibits prostate cancer cell growth and enhances the suppressive efficacy of androgen deprivation and docetaxel
Wandong Yu, Junhong Li, Qiang Wang, et al.
Journal of Medicinal Chemistry
|
October 21, 2021
Discovery of 1-Amino-1<i>H</i>-imidazole-5-carboxamide Derivatives as Highly Selective, Covalent Bruton's Tyrosine Kinase (BTK) Inhibitors
Chunhua Ma, Qingyun Li, Minghao Zhao, et al.
Journal of Medicinal Chemistry
|
May 15, 2025
Discovery of Imidazo[1,2-<i>b</i>]pyridazine Derivatives as Potent and Highly Selective Irreversible Bruton's Tyrosine Kinase (BTK) Inhibitors
Dandan Zhang, Jie Zhao, Guiqing Xu, et al.
Page
of 3